A Prospective Study to Collect High-Quality Documentation of Bleeds, Health-Related Quality of Life (HRQoL), and Safety Outcomes in Patients With Hemophilia A Treated With Standard-of-Care Treatment

NCT02476942 · clinicaltrials.gov ↗

COMPLETED

Status

221

Enrollment

INDUSTRY

Sponsor class

Conditions

Hemophilia A

Interventions

DRUG: Bypassing Agents
DRUG: FVIII Replacement

Sponsor

Hoffmann-La Roche